Obesity

The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity

DiabetologiaPublished Prospective cohort study

Authors' conclusion

Bariatric surgery may be an effective approach to reverse PN in individuals with obesity. The observed stability of CAN and retinopathy may be an improvement compared with the natural progression of these conditions; however, controlled trials are needed.

Study context

Population
Individuals with class II/III obesity (BMI > 35 kg/m²) undergoing bariatric surgery; age 46.0 ± 11.3 years, 73.4% female79 completed follow-up
Participants
127 individuals
Exposure
Before vs 2 years after bariatric surgery
  • Bariatric surgeryn = 127
Outcome
PN: change in IENFD (fibres/mm) at distal leg and proximal thigh; CAN: change in E/I ratio; retinopathy: change in mean deviation on frequency doubling technology testing
Follow-up
2 years following surgery

Main finding

As reported in the abstract

Change in primary complication outcomes · 2 years

Intra-epidermal nerve fibre density (IENFD) proximal thigh (peripheral neuropathy (PN)) improved

+3.4 ± 7.8

p<0.01

Cardiovascular autonomic neuropathy (CAN) (E/I ratio) stable

−0.01 ± 0.1

p=0.89

Retinopathy (mean deviation) stable

−0.2 ± 3.0

p=0.52

Observational data: associations, not effects.

Further findings

Weight loss · 2 years following surgery

Mean weight lost by participants
31.0 kg (SD 18.4)
All metabolic risk factors improved except BP and total cholesterol

Fasting glucose reduction and retinopathy (linear regression)

Greater reduction in fasting glucose associated with improvement in retinopathy (mean deviation point estimate)
−0.7 (95% CI −1.3, −0.1)

Original publication

The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity. Diabetologia. Published 14 March 2023. doi:10.1007/s00125-023-05899-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.